News

Phase I Study of PSMA Targeted 225Ac-J591 Reveals Tolerability in mCRPC

07/13/2021

225Ac-J591 receives first human study with research in PSMA targeting and dose expansion capabilities during an ongoing phase I trial.

225Ac-J591 receives first human...

07/13/2021

Oncology

Radiogland Therapy Demonstrates Promising Results in PSMA-Positive mCRPC

07/13/2021

177Lu-PSMA-617 met both primary endpoints and substantially improved OS and rPFS outcomes in patients with PSMA-positive metastatic castration-resistant prostate cancer, according to the phase III VISION study.

177Lu-PSMA-617 met both primary...

07/13/2021

Oncology

Conference Insider

Ripretinib Yields Clinical Benefit; Proven Tolerability in Advanced GIST

06/17/2021

INVICTUS study results reveal intra-patient dose escalation (IPDE) of ripretinib after disease progression indicate clinical benefit and tolerability in patients with advanced gastrointestinal stromal tumors.

INVICTUS study results reveal...

06/17/2021

Oncology

Conference Insider

Experts Investigate Value of Chromosomal Complexity in Imatinib Treatment for High-Risk GIST

06/17/2021

Investigators sought to determine if chromosomal complexity could be used as a biomarker in de-escalation of adjuvant imatinib treatment, presented at the 2021 ASCO Annual Meeting.

Investigators sought to...

06/17/2021

Oncology

Press Release

MolecuLight Launches the i:X® Telemedicine Solution for Imaging of Bacteria in Wounds

07/16/2020

New Telemedicine Solution allows the MolecuLight i:X Device to be used at the Bedside for Synchronous Interpretation of the Images by Remote Wound Care Clinicians

New Telemedicine...

07/16/2020

Wound Care

Press Release

MolecuLight Launches i:X® Sterile Surgical Sleeve for Imaging of Bacteria in Wounds in a Surgical Setting

07/09/2020

New Disposable Sleeve allows MolecuLight i:X to Be Used in Operating Rooms (for skin grafts and skin substitutes), in Covid-19 Wards and in MRSA Isolation Wards

New Disposable Sleeve allows...

07/09/2020

Wound Care

Press Release

MTF Biologics Wound Care Tissue Forms Now Accessible to Over 240 Million Americans

06/22/2020

New positive coverage decisions with Aetna™, Centene Corporation®, WellCare® and Tufts Health Plan provide greater access to MTF Biologics Wound Care Tissues, AmnioBand® and AlloPatch®, to millions of Americans who suffer from complex and...

New positive coverage decisions...

06/22/2020

Wound Care